Innovis Pharma becomes member of the PharmaPath Group
Innovis Pharma announces the completion of its acquisition by PharmaPath, marking a new phase of growth.
This milestone establishes a fully integrated platform—combining R&D, manufacturing, and commercial capabilities—strengthening its position as a trusted provider of high-quality, accessible medicines in Greece and contributing to the future of healthcare.
Read the press release here.
-
1 June 2023Gx portfolio acquisitionInnovis further expands its Gx product portfolio in GreeceVIEW MORE